​​​Jamie K. Alan

CMU College of Medicine

Specialty: Pharmacology, Pharmacy, Genetics, Drug Discovery, Molecular Biology, C. elegans

CMED Research Building, Room 121
Mount Pleasant, MI 48859
Phone: 989-774-6582
Fax: 989-774-3752

Jamie K. Alan, RPh, PharmD, PhD, is an Assistant Professor of Pharmacology in the Foundational Sciences Discipline in the College of Medicine. Dr. Alan received her PharmD from Ohio Northern University in 2005, where she graduated with high distinction. She has been a licensed and practicing pharmacist for 8 years and has experience in retail, hospital, clinical and compounding pharmacy along with experience in conducting and designing clinical trials.

Dr. Alan received her PhD in Pharmacology from the University of North Carolina at Chapel Hill (UNC-CH) in 2010. In her doctoral work, Dr. Alan studied the regulation of small GTPases and how their regulation/dysregulation impacts tumorigenesis, cell migration and metastasis. Dr. Alan's main doctoral work focused on studying regulation of the atypical Rho GTPase, Wrch-1 (Wnt-regulated Cdc-42 homolog-1). While at UNC-CH, Dr. Alan was active in the Cell and Molecular Biology (CMB) group, where she worked to develop and implement an undergraduate program focused on providing a mentored research experience.

Dr. Alan did her postdoctoral work at the University of Kansas (KU). As a postdoctoral fellow, she studied the role of atypical Rho proteins in neuronal migration in the model organism Caenorhabditis elegans (C. elegans). Dr. Alan identified several novel pathways that regulate the atypical Rho GTPase chw-1 (Chp/Wrch-1). During her time at the University of Kansas, Dr. Alan co-founded and served as co-president for the University of Kansas Postdoctoral Association.

Dr. Alan's current research combines genetics, molecular biology, cancer biology and pharmacology. She studies the role of the atypical Rho GTPase Wrch-1 in tumorigenesis, cell migration and metastasis in both C. elegans and in cellulo using cell culture techniques. Dr. Alan is also currently developing a high-throughput drug screen for Rho GTPases using C. elegans as an "in vivo" test tube that will be used for drug discovery.

Education & Fellowships:
  • Post-Doctoral Fellowship:
    • The University of Kansas,
      Department of Molecular Biosciences
      Advisor: Dr. Erik Lundquist
      Lawrence, KS
  • PhD:
    • The University of North Carolina - Chapel Hill
      PhD, Pharmacology - 2010
      Department of Pharmacology
      Advisor: Dr. Adrienne Cox
      Chapel Hill, NC
  • PharmD:
    • Ohio Northern University
      PharmD - 2005
      Ada, OH
  • Kansas pharmacist license
  • North Carolina pharmacist license
  • Ohio pharmacist license
  • Certified in vaccination administration (Ohio)
  • Certified in smoking cessation counseling (Ohio)
  • Training Initiative in Biomedical and Biological sciences (TIBBS) College Teaching Certificate, UNC-CH, 2006
Specialty Interests:
Pharmacology, Pharmacy, Drug discovery and development, Drug screening, Cancer biology, Genetics, Molecular biology, Cancer biology, C. elegans

Awards & Honors:
  • Cell and Molecular (CMB) Biology NIH-funded T32 Training Grant
  • UNC Office of Undergraduate Research (OUR) Undergraduate Mentor Award
  • Former Co-President and Co-Founder of the University of Kansas Postdoctoral Association-Nominated for KU Organization of the Year.
  • Editorial Board Member- PostDoc Journal (2012- Present)
  • Reviewer- Journal of Student Research (2012 – Present)
  • National Postdoctoral Association (2011-2013)
  • Genetics Society of America (2010-Present)
  • Rho Chi (Academic Honor Society in Pharmacy)
  • Alpha Lambda Delta (National Honor Society)

Specialty in Diseases and Conditions:
  • Cancer Biology
Language Spoken:
  • English